SCHEMBL5580894

SCHEMBL5580894

O=C(O)Cc1cc(F)cc(-c2cccc(OCC=Cc3ccc(C(F)(F)F)cc3)c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 4/20 0.44
RXRB P28702 3/20 0.44
RXRG P48443 3/20 0.44
PPARG P37231 2/20 0.43
PTGES O14684 1/20 0.43
ALOX5 P09917 1/20 0.43
PSEN1 P49768 1/20 0.43
PPARD Q03181 7/20 0.42
LTB4R Q15722 1/20 0.41
LTB4R2 Q9NPC1 1/20 0.41
PPARA Q07869 3/20 0.41
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
FFAR1 O14842 2/20 0.39
PTPN2 P17706 1/20 0.39
PTPN1 P18031 1/20 0.39
PTPN6 P29350 1/20 0.39
S1PR5 Q9H228 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5580891 1.00 RXRA (0.44) RXRARXRBRXRGPPARGPTGES
SCHEMBL5580432 0.91 RXRA (0.46) RXRARXRBRXRGPPARGPTGES
SCHEMBL5580428 0.91 RXRA (0.46) RXRARXRBRXRGPPARGPTGES
SCHEMBL5580614 0.90 PPARD (0.46) RXRARXRBRXRGPPARGPTGES
SCHEMBL5580617 0.90 PPARD (0.46) RXRARXRBRXRGPPARGPTGES
SCHEMBL5580781 0.86 CYP11B1 (0.45) RXRARXRBRXRGPPARGPTGES
SCHEMBL5580788 0.86 CYP11B1 (0.45) RXRARXRBRXRGPPARGPTGES
SCHEMBL5580791 0.84 PSEN1 (0.47) RXRARXRBRXRGPPARGPTGES
SCHEMBL5580784 0.84 PSEN1 (0.47) RXRARXRBRXRGPPARGPTGES
SCHEMBL5580642 0.83 PTGER2 (0.41) RXRARXRBRXRGPPARGPTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070105959-A1 Cynnamyl alcohol derivative compounds and drugs containing the compounds as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2007-05-10 US claimed
EP-1604971-A1 CINNAMYL ALCOHOL DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2005-12-14 EP claimed
US-20070105959-A1 Cynnamyl alcohol derivative compounds and drugs containing the compounds as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2007-05-10 US disclosed
EP-1604971-A1 CINNAMYL ALCOHOL DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2005-12-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105959-A1 Cynnamyl alcohol derivative compounds and drugs containing the compounds as active ingredient LPL, GPR119, EBP RXRA 475/4885RXRB 668/4885RXRG 208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.